J Korean Med Sci.  2023 Sep;38(37):e299. 10.3346/jkms.2023.38.e299.

Comprehensive Analysis of Iron Deficiency Anemia and Its Related Disorders in Premenopausal Women Based on a Propensity Score Matching Case Control Study Using National Health Insurance Service Database in Korea

• Lee HJ
• Pak H
• Han JJ
• Chang MH

• KMID: 2546203
• DOI: http://doi.org/10.3346/jkms.2023.38.e299

Abstract

Background
Menorrhagia is a common cause of iron deficiency anemia (IDA) in premenopausal women. However, the effects of menorrhagia on IDA in premenopausal women have been underestimated compared to those on other IDA-related disorders (IRDs) such as gastrointestinal malignancies (GIMs). To better understand the relationship between menorrhagia and IDA in premenopausal women, we analyzed the National Health Insurance Service-National Health Information Database (NHIS-NHID).
Methods
From 2005 to 2008, data about women between the age of 20 and 59 years were extracted from the NHIS-NHID to create a propensity score-matched case (IDA) and control group. The annual incidence of IDA was calculated per age group. A 10-year follow up of the study population was determined to detect IRDs in case and control groups. We compared the risk of detection (ROD) of IRDs, including GIM and gynecological disorders associated with menorrhagia - leiomyoma of uterus (LM) and adenomyosis (AM), in the case and the control group.
Results
From 2005 to 2008, women diagnosed with IDA (n = 535,249) and healthy women as a control group (n = 1,070,498) were identified from the NHIS-NHID. The annual incidence of IDA was 767.4 (2005), 948.7 (2006), 981.6 (2007), and 897.7 (2008) per 100,000 women. The age distribution of IDA was similar each year; IDA was common in women aged 30–39 years (36–37%) and 40–49 years (30–32%), and its incidence was significantly decreased in women aged 50–59 years (< 10%). The ROD of IRDs were significantly higher in the IDA group than in the control group (LM: 20.8% vs. 6.9%, AM: 5.6% vs. 1.6%, and GIM: 2.6% vs. 0.7%). The corresponding hazard ratios were 3.89 (95% confidence interval [CI], 3.85–3.93) for LM, 4.99 (95% CI, 4.90–5.09) for AM, and 3.43 (95% CI, 3.32–3.55) for GIM. The ROD of the IRDs varied; the ROD of LM in the IDA group increased with age and decreased in the age group 50–59 years. AM was more frequently detected in women with IDA aged 30–39 years and less in women older than 40 years. The frequency of GIM increased with age.
Conclusion
In this study, we found that the gynecologic disease is the main cause of IDA in premenopausal women. Gynecological evaluations should be performed more actively in the clinic to prevent and control IDA and IRDs.

Keyword

Anemia; Iron-Deficiency; Leiomyoma of Uterus; Adenomyosis; Gastrointestinal Malignancies

Figure

• 

  Fig. 1 Total annual number of newly diagnosed IDA cases by age group.IDA = iron deficiency anemia.

• 

  Fig. 2 The relative risk of detection of IDA related disorders. The relative risk of detection of IDA related disorders were calculated. (A) Leiomyoma of uterus. (B) Adenomyosis. (C) Gastrointestinal malignancies.HR = hazard ratio, CI = confidence interval.

Reference

1. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014; 123(5):615–624. PMID: 24297872.

2. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr. 2000; 71(5):Suppl. 1280S–1280S. PMID: 10799402.

3. Carter RC, Jacobson JL, Burden MJ, Armony-Sivan R, Dodge NC, Angelilli ML, et al. Iron deficiency anemia and cognitive function in infancy. Pediatrics. 2010; 126(2):e427–e434. PMID: 20660551.

4. Eisenstaedt R, Penninx BW, Woodman RC. Anemia in the elderly: current understanding and emerging concepts. Blood Rev. 2006; 20(4):213–226. PMID: 16472893.

5. Haas JD, Brownlie T 4th. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001; 131(2):2S-2. 676S–88S. PMID: 11160598.

6. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization;2002.

7. World Health Organization. Worldwide Prevalence of Anaemia 1993–2005: WHO Global Database on Anaemia. Geneva, Switzerland: World Health Organization;2008.

8. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013; 1(1):e16–e25. PMID: 25103581.

9. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015; 373(5):485–486.

10. Korea Disease Control and Prevention Agency. The 7th Korean National Health and Nutrition Examination Survey (KNHNES-VII). Updated 2022. Accessed 4 June, 2022. https://knhanes.kdca.go.kr/knhanes/sub04/sub04_04_01.do .

11. Lee JO, Lee JH, Ahn S, Kim JW, Chang H, Kim YJ, et al. Prevalence and risk factors for iron deficiency anemia in the Korean population: results of the fifth Korea National Health and Nutrition Examination Survey. J Korean Med Sci. 2014; 29(2):224–229. PMID: 24550649.

12. Breymann C, Auerbach M. Iron deficiency in gynecology and obstetrics: clinical implications and management. Hematology Am Soc Hematol Educ Program. 2017; 2017(1):152–159. PMID: 29222250.

13. Kepczyk T, Cremins JE, Long BD, Bachinski MB, Smith LR, McNally PR. A prospective, multidisciplinary evaluation of premenopausal women with iron-deficiency anemia. Am J Gastroenterol. 1999; 94(1):109–115. PMID: 9934740.

14. Kasper DL. Harrison’s Principles of Internal Medicine. 19th ed. New York, NY, USA: McGraw Hill Education Medical;2015.

15. Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, et al. Data resource profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017; 46(3):799–800. PMID: 27794523.

16. Statistical Geographic Information Service. Updated 2023. Accessed June 16, 2022. https://sgis.kostat.go.kr/view/index .

17. Lee HJ, Park HY, Park SY, Chang MH. A Study to evaluate the efficacy of health screening service and suggest the optimal management plan for premenopausal women with iron deficiency anemia National Health Insurance Hospital. Updated 2020. Accessed June 16, 2022. https://www.nhimc.or.kr/research/board/commBoardRscTestBigDList.do?page=2&searchyyyy=2019 .

18. Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of uterine myomas: a review. Int J Fertil Steril. 2016; 9(4):424–435. PMID: 26985330.

19. Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011; 18(4):428–437. PMID: 21622029.

20. Lee M, Chung YJ, Kim HK, Hwang H, Park JY, Shin I, et al. Estimated prevalence and incidence of uterine leiomyoma, and its treatment trend in South Korean Women for 12 years: a national population-based study. J Womens Health (Larchmt). 2021; 30(7):1038–1046. PMID: 32991229.

21. Choi EJ, Cho SB, Lee SR, Lim YM, Jeong K, Moon HS, et al. Comorbidity of gynecological and non-gynecological diseases with adenomyosis and endometriosis. Obstet Gynecol Sci. 2017; 60(6):579–586. PMID: 29184867.

22. Kim JW, Kim SH, Kang JK. A study on the relationship between attitude to sex and prevention efforts against cervical cancer among Korean women in their 20s. J Korean Soc Sch Community Health Educ. 2021; 22(2):15–23.

23. Choi WM, Han NK, Chung W. Factors associated with the non-screening status of cervical cancer screening test in Korean adult women: Korea National Health and Nutrition Examination Survey (2010–2012). Health Policy Manag. 2019; 29(4):399–411.

24. Clancy KB, Nenko I, Jasienska G. Menstruation does not cause anemia: endometrial thickness correlates positively with erythrocyte count and hemoglobin concentration in premenopausal women. Am J Hum Biol. 2006; 18(5):710–713. PMID: 16917885.

25. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022; 54(2):330–344. PMID: 35313102.

26. Kim SJ, Ha SY, Choi BM, Lee MY, Jin JY, Yeom SJ, et al. The prevalence and clinical characteristics of cancer among anemia patients treated at an outpatient clinic. Blood Res. 2013; 48(1):46–50. PMID: 23589795.